Pond Technologies Announces Grant of Stock Options May 13, 2021

Rhea-AI Summary

Pond Technologies Holdings Inc. (OTCQB:PNDHF) has granted 200,000 stock options to eligible consultants at an exercise price of $0.67 per share. These options have a 3-year term and will vest in increments over two years. The closing share price on May 12, 2021, matched the exercise price. Pond Technologies focuses on sustainable cultivation of micro-algae, utilizing advanced technology to enhance productivity and reduce CO2 emissions. The company is expanding its offerings in pharmaceuticals, cosmetics, and biofuels through technology licensing and a new Biotech division.

Positive

• Granting 200,000 stock options can encourage consultants to drive company growth.
• Pond's technology leverages CO2 from waste, promoting sustainability.
• Expansion into pharmaceuticals and cosmetics via micro-algae is promising for revenue diversification.

Negative

• None.

MARKHAM, ON / ACCESSWIRE / May 14, 2021 / Pond Technologies Holdings Inc. ("Pond") (TSX.V:POND); (OTCQB:PNDHF); (FSE:4O0), an ESG company addressing global sustainability challenges of wellness and climate change announces that on May 13, 2021 it granted an aggregate of 200,000, stock options (the "Options") to eligible consultants under the Corporation's existing stock option plan. Each Option is exercisable for one common share of the Corporation at an exercise price of $0.67 per share. The closing price of the common shares of the Corporation on the TSX Venture Exchange on May 12, 2021 was $0.67. The Options have a term of 3 years and vest as to one-half on the date of grant, one-quarter on the first anniversary of the date of grant, and the balance on the second anniversary of the date of grant.

About Pond Technologies Holdings Inc.:

Located in Markham, Ontario, Pond Technology is a technology leader in controlled environment cultivation of micro-algae. In over ten years of R&D, Pond has developed a robust disruptive technology platform based on artificial intelligence, proprietary LED-lights and patented CO2-Management. The use of concentrated CO2 from industrial waste streams enables Pond to boost productivity of micro-algae well beyond the capacity of outdoor algae growers and allows industrial emitters to abate and ultimately recycle CO2. Pond is currently selling micro-algae derived antioxidant Astaxanthin under its Regenurex brand. As micro-algae are becoming increasingly important in pharmaceuticals and cosmetics, nutraceuticals, human nutrition, aqua farming, bioplastics and biofuels, Pond has begun to license its technology to third parties for ongoing license fees and royalties. Pond recently added a Biotech division focused on the growth of unique strains of micro-algae to be used as a reproductive medium for the expression of human anti-bodies and proteins.

For more information, please visit https://www.pondtech.com/.

Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.

For further information contact: Grant Smith, Chief Executive Officer, at g.smith@pondtech.com, 416-287-3835 ext. 201; or Cole Stevens at c.stevens@pondtech.com

SOURCE: Pond Technologies Holdings Inc.

View source version on accesswire.com:
https://www.accesswire.com/647589/Pond-Technologies-Announces-Grant-of-Stock-Options-May-13-2021

FAQ

What stock options did Pond Technologies grant on May 13, 2021?

Pond Technologies granted 200,000 stock options at an exercise price of $0.67 per share.

What is the significance of the stock option exercise price for PNDHF?

The exercise price of $0.67 per share matches the closing price on May 12, 2021, indicating no immediate financial advantage.

How long are the stock options valid for Pond Technologies?

The stock options are valid for a term of 3 years.

What areas is Pond Technologies expanding into?

Pond Technologies is expanding into pharmaceuticals, cosmetics, and biofuels using its micro-algae technology.

What is the focus of Pond Technologies' new Biotech division?

The new Biotech division focuses on growing unique strains of micro-algae for the expression of human antibodies and proteins.